Is endometriosis a benign disease? Modern controversial aspects of endometriosis-associated ovarian tumors

Condition tags

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (60)

• A dose-ranging study to determine the efficacy and safety of 1, 2, and 4mg of dienogest daily for endometriosis via openalex
• Big picture of endometriosis helps provide guidance on approach to teens: comparative historical data show endo starting younger, is more severe via openalex
• Cancer risk after hospital discharge diagnosis of benign ovarian cysts and endometriosis via openalex
• Comparison of clinical outcomes of patients with clear cell and endometrioid ovarian cancer associated with endometriosis to papillary serous carcinoma of the ovary via openalex
• Consensus on current management of endometriosis via openalex
• Current strategies for endometriosis management via openalex
• Dienogest: an oral progestogen for the treatment of endometriosis via openalex
• Dienogest: a review of its use in the treatment of endometriosis via openalex
• Dienogest, a synthetic progestin, down-regulates expression of CYP19A1 and inflammatory and neuroangiogenesis factors through progesterone receptor isoforms A and B in endometriotic cells via openalex
• Dienogest, a synthetic steroid, suppresses both embryonic and tumor-cell-induced angiogenesis via openalex
• Dienogest increases the progesterone receptor isoform B/A ratio in patients with ovarian endometriosis via openalex
• Effectiveness of the cyclic administration of dienogest in a case of pathological disappearance of intestinal endometriosis via openalex
• Effect of dienogest administration on angiogenesis and hemodynamics in a rat endometrial autograft model via openalex
• Endometriosis via openalex
• Endometriosis: a life cycle approach? via openalex
• Endometriosis-associated Malignancy via openalex
• Endometriosis in premenarcheal girls who do not have an associated obstructive anomaly via openalex
• Epidemiology of endometriosis via openalex
• Evidence of a genetic link between endometriosis and ovarian cancer via openalex
• Increased risk for ovarian cancer and borderline ovarian tumours in subfertile women with endometriosis via openalex
• In vitro fertilization, endometriosis, nulliparity and ovarian cancer risk via openalex
• Malignant Transformation from Endometriosis to Atypical Endometriosis and Finally to Endometrioid Adenocarcinoma within 10 Years via openalex
• New insights in the pathophysiology of ovarian cancer and implications for screening and prevention via openalex
• On-label and off-label drug use in the treatment of endometriosis via openalex
• Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis via openalex
• Ovarian cancer risk associated with varying causes of infertility via openalex
• Postmenopausal cancer risk after self-reported endometriosis diagnosis in the Iowa Women's Health Study via openalex
• Postoperative medical therapy after surgical treatment of endometriosis: from adjuvant therapy to tertiary prevention via openalex
• Prognostic implication of endometriosis in clear cell carcinoma of the ovary via openalex
• Recurrence of endometriosis after hysterectomy via openalex
• Revised American Society for Reproductive Medicine classification of endometriosis: 1996 via openalex
• Risk and prognosis of ovarian cancer in women with endometriosis: a meta-analysis via openalex
• Risk of developing major depression and anxiety disorders among women with endometriosis: A longitudinal follow-up study via openalex
• Role of angiogenesis in endometriosis via openalex
• The Association between Endometriomas and Ovarian Cancer: Preventive Effect of Inhibiting Ovulation and Menstruation during Reproductive Life via openalex
• Theories on the pathogenesis of endometriosis via openalex
• The relation between endometriosis and ovarian cancer - a review via openalex
• The risk of cancer and the role of parity among women with endometriosis via openalex
• Treatment of Endometriosis with the GnRHa Deslorelin and Add-Back Estradiol and Supplementary Testosterone via openalex
• W2163064788 via openalex
• W2226711154 via openalex
• W2230403972 via openalex
• W1718276241 via openalex
• W4233104412 via openalex
• W1647658753 via openalex
• W1523215342 via openalex
• W6690080468 via openalex
• W2090702820 via openalex
• W2030404955 via openalex
• W2109870736 via openalex
• W2114410175 via openalex
• W2000311445 via openalex
• W2139087961 via openalex
• W2139888809 via openalex
• W1974756790 via openalex
• W1964254460 via openalex
• W2155216639 via openalex
• W2158187504 via openalex
• W2159575833 via openalex
• W1804864865 via openalex

Cited by (4)

• Ultrasound image of ovarian endometrioma as an indicator of external genital endometriosis 2024
• Risk factors for recurrence of ovarian endometriomas after surgical treatment: retrospective cohort study 2021
• Incidence rate and structure of external genital endometriosis in hospital patients 2021
• The value of the assesment of ARID1A expression, prostaglandin E2 synthase and the prostaglandin E2 receptor in patientswith genital endometriosis 2019

Source provenance

openalex

last seen: 2026-06-10T17:14:06.276822+00:00